Stockreport

Longeveron stock rallies 85% on Alzheimer's presentation (update) [Seeking Alpha]

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF study for its therapy Lomecel-B in the treatment of mild Alzheimer's disease at the Alzheimer's Association International Conference in July. Longeveron plans to make [Read more]